Checking the Status of Your Manuscript
All authors can check the status of their submitted manuscript at any time at https://www.editorialmanager.com/medpharmres
Understanding Your Manuscript Status
The journal has received the submission and is conducting an initial editorial assessment and screening for technical requirements.
The journal office is identifying potential editors to handle the submission.
The manuscript has been placed with a member of the editorial board for handling.
The handling editor has invited peer reviewers to evaluate the submission.
Required reviews complete
Some or all assigned reviewers have submitted comments.
Decision in process
The handling editor has drafted a decision, but it has not yet been finalized or sent to the authors.
Editorial and Peer Review Policy
MedPharmRes applies a single-blinded peer review process (the reviewers know the authors name but not vice-versa) with a rigorous editorial screening and assessment process involving several stages. These processes are carried out through the Editorial Manager System by Aries Systems Corporation, USA. Only manuscripts that meet our editorial criteria will be sent for review, typically by two or three reviewers. The manuscript will be reviewed and evaluated based on originality, technical research, and relevance to journal contributions.
Editorial staff perform an initial quality check each submitted manuscript to identify potential issues such as
- Competing interests
- Compliance with editorial policies and ethical standards
- Financial disclosures
- Data availability
- Authorship confirmation
Submissions may be returned to authors for changes or clarification at this stage.
After completing internal checks, each new submission is assigned to an Academic Editor with relevant expertise. The handling editor reviews the manuscript against our publication criteria and determines whether reviews from additional experts are needed to evaluate the manuscript. The handling Academic Editor is usually a member of the MedPharmRes Editorial Board, but occasionally a Guest Editor is invited to serve instead.
During the submission process authors will be asked to indicate any specific editors or reviewers who should not review the manuscript. We will respect authors’ request so long as it does not interfere with the objective and thorough assessment of the submission.
The handling editor selects reviewers based on expertise, publication history, and review’s history, and invites them to provide feedback on the manuscript. After agreeing to review, external peer reviewers typically have 10 days to submit their review. The journal officers will follow up with late reviewers and keep authors informed if there are any delays.
MedPharmRes uses single-blinded peer-review process. Reviewers remain anonymous unless they choose to show themselves by signing their name to their review in our submission system.
The handling Academic Editor makes the final decision on each manuscript based on reviewers’ advices. The time to render a first decision averages about 60 days, but times vary depending on how long it takes for the editor to receive and assess reviews.
The editor makes decision on the manuscript based on reviewers’ suggestions and their own evaluation. Decision will be e-mailed to the corresponding author, with reviewers’ feedbacks and any other requirements from the journal. The following decision types are available:
- Major revision
- Minor revision
The reviewers think that the manuscript cannot be revised in its current form. However, the authors can comprehensively revise the manuscript that can be submitted as a de-novo submission.
Major and Minor Revisions
The editor feels that the manuscript has potential to be published but requires substantial changes. Authors have up to three months to revise their manuscripts, as judged by the handling editor. Authors who expect to need extra time for revision are required to contact the Editorial Office within one week before the deadline to request an extension. Authors whose manuscripts are deemed by the handling editor to require more than three months for revision will be requested to submit their revised work a new submission.
The revised manuscript is re-assigned to the first handling Academic Editor. The revised manuscript will be typically sent to the reviewers of the original manuscript for their comments. The editor gives a new decision based on his/her own evaluation of the revised manuscript and your responses to reviewers, and new requests from the reviewers.
When the handling editor is satisfied with the scientific aspects of the manuscript, he/she will issue a provisional accept decision that will be pending final checks for formatting and technical requirements. Once the final requirements are fulfilled, the journal office will send a formal accept decision, and the manuscript will move on to production for publication.
Proofing (Proofreading) is an essential stage in the editorial workflow before publication. During this phase, the editor or proofreader carefully checks and corrects the manuscript's language, spelling, grammar, sentence structure, and formatting errors. Proofing ensures that the article is free from mistakes and adheres to the established conventions of the field. This process ensures that the article is thoroughly prepared and of high quality before publication, guaranteeing clarity and accuracy in conveying information.
Peer Review History
Peer-review history contributes significantly to scientific records and increases transparency, accountability, and validity of research. If a manuscript is accepted for publication on MedPharmRes, authors and reviewers will be asked whether they accept to publish peer-review history of the accepted manuscript through a form generated from our submission system. If authors and peer-reviewers agree to publish peer-review history which will be published alongside with the final manuscript. In some cases of ethical consideration, MedPharmRes reserves the right not to publish peer review history.